| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.55B | 79.58B | 84.77B | 81.76B | 94.44B | 81.75B |
| Gross Profit | 9.10B | 8.64B | 13.93B | 14.21B | 16.55B | 15.44B |
| EBITDA | 11.32B | 8.52B | 7.57B | 10.81B | 12.73B | 11.69B |
| Net Income | 3.53B | 3.36B | 3.33B | 3.68B | 5.36B | 5.05B |
Balance Sheet | ||||||
| Total Assets | 74.49B | 74.22B | 69.88B | 66.81B | 68.28B | 63.59B |
| Cash, Cash Equivalents and Short-Term Investments | 7.80B | 5.08B | 2.19B | 2.08B | 3.19B | 4.71B |
| Total Debt | 29.09B | 25.44B | 24.21B | 20.83B | 20.22B | 19.02B |
| Total Liabilities | 50.62B | 51.60B | 45.66B | 43.92B | 44.58B | 44.09B |
| Stockholders Equity | 23.42B | 22.22B | 23.79B | 22.48B | 23.24B | 19.04B |
Cash Flow | ||||||
| Free Cash Flow | 6.20B | 5.39B | 5.79B | 5.88B | 7.05B | 6.26B |
| Operating Cash Flow | 8.98B | 8.07B | 8.72B | 9.26B | 10.96B | 9.99B |
| Investing Cash Flow | -5.08B | -4.74B | -2.39B | -2.18B | -3.18B | -4.82B |
| Financing Cash Flow | -4.71B | -3.35B | -6.35B | -6.90B | -7.41B | -6.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $17.57B | 11.18 | 14.20% | 2.98% | 15.87% | 1.18% | |
77 Outperform | $20.50B | 20.83 | 36.71% | 1.02% | 1.13% | 2.62% | |
72 Outperform | $62.59B | 15.32 | 16.07% | 3.81% | 5.10% | 16.57% | |
71 Outperform | $88.22B | 22.26 | 15.76% | 1.94% | 4.69% | 17.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $81.20B | 24.20 | 33.03% | 6.55% | -2.59% | -9.78% | |
57 Neutral | $23.54B | 56.34 | 19.04% | ― | 3.63% | -11.81% |